Cargando…

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment

Breast cancer, a hormone‐dependent tumour, generally includes four molecular subtypes (luminal A, luminal B, HER2 enriched and triple‐negative) based on oestrogen receptor, progesterone receptor and human epidermal growth factor receptor‐2. Multiple hormones in the body regulate the development of b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Kong, Xiangyi, Xuan, Lixue, Wang, Zhongzhao, Huang, Yen‐Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581311/ https://www.ncbi.nlm.nih.gov/pubmed/34651424 http://dx.doi.org/10.1111/jcmm.16946

Ejemplares similares

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer
por: Zhang, Ke, et al.
Publicado: (2023)

Prolactin and breast cancer.
por: Saluja, P. G., et al.
Publicado: (1973)

PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
por: Zhang, Ke, et al.
Publicado: (2022)

Prolactin: The Third Hormone in Breast Cancer
por: Schuler, Linda A., et al.
Publicado: (2022)

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020)

A Systematic Study on Zinc-Related Metabolism in Breast Cancer
por: Qu, Zheng, et al.
Publicado: (2023)

Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs
por: Cheng, Ran, et al.
Publicado: (2020)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2020)

Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers
por: Hathaway, Cassandra A., et al.
Publicado: (2023)

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data
por: Liu, Qiang, et al.
Publicado: (2020)

Plasma lipids and prolactin in patients with breast cancer.
por: Bani, I. A., et al.
Publicado: (1986)

Circulating levels of prolactin in human breast cancer.
por: Sheth, N. A., et al.
Publicado: (1975)

Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study
por: Ai, Bolun, et al.
Publicado: (2020)

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
por: Liu, Qiang, et al.
Publicado: (2021)

Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
por: Ali, Azlena, et al.
Publicado: (2015)

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2020)

Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor
por: Chen, Kuan-Hui Ethan, et al.
Publicado: (2021)

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy
por: López-Ozuna, Vanessa M., et al.
Publicado: (2016)

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
por: Qi, Yihang, et al.
Publicado: (2021)

Endocrine resistant breast cancer: brain metastasis
por: Willman, Matthew, et al.
Publicado: (2022)

NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis
por: Liu, Qiang, et al.
Publicado: (2021)

VAV3 mediates resistance to breast cancer endocrine therapy
por: Aguilar, Helena, et al.
Publicado: (2014)

Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
por: Arendt, Lisa M, et al.
Publicado: (2011)

The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
por: Yuan, Jie, et al.
Publicado: (2023)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Prognostic significance of serum prolactin levels in advanced breast cancer.
por: Dowsett, M., et al.
Publicado: (1983)

Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer
por: Nitze, Louise Maymann, et al.
Publicado: (2013)

Global profiling of prolactin-modulated transcripts in breast cancer in vivo
por: Sato, Takahiro, et al.
Publicado: (2013)

Plasma prolactin and breast cancer risk: a meta- analysis
por: Wang, Minghao, et al.
Publicado: (2016)

Suppression of Breast Cancer by Small Molecules That Block the Prolactin Receptor
por: Borcherding, Dana C., et al.
Publicado: (2021)

Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer
por: Ali, Suhad, et al.
Publicado: (2022)

Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer
por: Sauer, Natalia, et al.
Publicado: (2023)

Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qf4ini1i84d7ho89gavdt9nv2a